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Abstract 
Introduction: Wine is worldwide known drink with a long history. It is popular in many 
cultures and diets. It is a component of Mediterranean diet, which is an example of healthy 
eating. Red wine seems to be an essential component of the diet, since moderate consumption 
of wine is associated with lower risk and mortality from cardiovascular disease. 
The aim of the study: The purpose of this systemic review was to collect and analyse 
available data about health properties of wine. 
Material and method: Standard criteria were used to review the literature data. The search of 
articles in the PubMed database was carried out using the following keywords: wine, alcohol, 
cardiovascular, polyphenols. 
Description of the state of knowledge: Pro-health properties of alcohol depends mainly on 
the content of polyphenols. The most biologically active polyphenol is resveratrol. Light 
drinking of wine has multiple beneficial effects. It decreases level of  total plasma cholesterol, 
low-density lipoprotein and increases high-density lipoprotein, lowers blood fibrinogen, 
thromboxane A, platelet stickiness, reducing insulin resistance, inhibits inflammation, 
improves endothelial function, fibrinolysis and increases plasma concentration of atrial 
natriuretic peptide. In addition it may have neuroprotective effect and beneficial effect on gut 
microbiota. 
Summary: Moderate wine consumption can be beneficial for our health, may protect against 
cardiovascular disease, atherosclerosis, hypertension, certain types of cancer, type 2 diabetes, 
neurological disorders and metabolic syndrome. Nevertheless, any amount of alcohol 
consumed can lead to alcohol addiction and there is a very thin line between drinking small 
amounts and abuse. Furthermore, there are studies indicating that small amounts of alcohol 
can also have a negative impact on health. This subject still needs more studies and clinical 
trials. 
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1. Introduction 
Red wine is a worldwide known drink with a long history since it was popular even in 
ancient times [1]. Wine can be found in many cultures, but especially in Mediterranean diet 
[2]. Low to moderate red wine consumption can be beneficial for our health since it is 
associated with lower mortality from cardiovascular and cerebrovascular disease [3]. 
However, it is very important to emphasize that it only applies to light drinking. It is well 
known that alcohol can have many negative and serious health effects. Harmful use of alcohol 
is responsible for 5.9% of all deaths, and 5.1% of the global burden of disease [4]. 
Nevertheless, the French paradox exists and is associated with a daily glass of wine [5]. Red 
wine seems to have some positive effects, so the aim of this article is to discuss how it can 
influence our health. 
2. Polyphenols 
Red wine is known as a source of phenolics since it contains 10-fold more phenolic 
compounds than white wine [6]. For white wines the concentration of polyphenol content is 
around 50-400 mg/L, while for red wines it is 900-1400 mg/L. The differences in 
concentration appear due to differences in enological practices and regarding grape like 
variety, soil and climate. Red wine phenolics can be divided into two major groups: 
flavonoids (flavan‐3‐ols, the flavonols, and the anthocyanins) and non-flavonoids 
(hydroxycinnamates, hydroxybenzoates and the stilbenes) [7,8]. The benefits of red wine are 
studied since the discovery of the French paradox [9], which is low rates of coronary heart 
disease and low risk of cardiac mortality in the French populace despite of high intakes of 
dietary cholesterol and saturated fat [10]. These phenolics reduce low-density lipoprotein 
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(LDL) cholesterol oxidation and reduce platelet aggregation which contribute to lower risk of 
coronary diseases [11]. Both long-term abuse of alcohol and binge drinking are associated 
with atrial fibrillation. However, this relationship is not that certain with light and moderate 
drinking [9]. Studies show that light-to-moderate alcohol consumers have an increased 
survival compared to abstainers [11]. All the benefits are associated with flavonoids that are 
polyphenolic compounds. It is commonly known that high intake of fruits and vegetables is 
beneficial for our health [12,13].One of the reasons is high content of flavonoids in these 
foods [13]. 
Flavonols are a diverse family of monomeric (catechin, epicatechin), oligomeric and 
polymeric (proanthocyanidins, also called condensed tannins) chemical compounds. The 
astringency, bitterness, and structure of wines depend on catechin and epicatechin which can 
be found in skin and seeds of grape [6]. Anthocyanins are pigments found in plants, flowers 
and fruits [7]. Tannins may be divided into two groups: hydrolysable tannins and condensed 
tannins (also named catechin tannins or proanthocyanidins) [14]. Many studies show the 
beneficial effects on health of tannins mostly due to its antioxidant properties and, thus, could 
help in the prevention of inflammation disorders, cardiovascular diseases, or have protective 
effects to lower the risk of various cancers [14,15]. Another compound is resveratrol that is 
responsible for multiple biological effects. However, the way of action of resveratrol is not 
fully known yet [16]. The variety of molecular targets of resveratrol seems to be the key of its 
mechanism of action [16,17]. Studies showed that resveratrol has beneficial effect on 
cardiovascular system [18,19,20], cancer treatment [21,22], has antioxidant and 
immunomodulatory effects for some autoimmune diseases [23], anti-diabetic effects [24] and 
neuroprotective activity [25]. 
3. Wine and cardiovascular health 
Drinking wine definitely has an impact on functioning of the cardiovascular system. 
Moderate wine intake reduces cardiovascular risk [26]. It decreases level of  total plasma 
cholesterol, low-density lipoprotein (LDL) and increases high-density lipoprotein [11]. It also 
causes less LDL oxidation, which in vessel wall promotes atherosclerosis [27]. In addition to 
the positive effects on cholesterol, the wine has many other positive effects. It lowers blood 
fibrinogen, thromboxane A, platelet stickiness. This effects decrease clot formation in 
atherosclerotic blood vessels [27]. It lowers the risk of type 2 diabetes mellitus, probably by 
reducing insulin resistance, inhibits inflammation, improves endothelial function, fibrinolysis 
and increases plasma concentration of atrial natriuretic peptide [28,29,30]. Wine contains 
resveratrol(3,5,4'‐trihydroxy‐trans‐stilbene) – one of the most biologically active polyphenols 
[26].It lowers production of reactive oxygen species (ROS) , because it  inhibits NADPH-
oxidase by down-regulating its expression and activity [31]. ROS cause oxidative stress and 
contribute do development of cardiovascular disease, such as ischemic heart disease, 
hypertension, cardiac hypertrophy, atherosclerosisand congestive heart failure [26].  
Literature reports that resveratrol may have anti-arrhythmic effects and may act as inhibitor of 
both intracellular calcium release and pathological signaling cascades in atrial fibrillation [9]. 
There are several preclinical studies on animal models that show protective effect of 
resveratrol on cardiovascular disease, such as hypertension, hypercholesterolemia, ischaemic 
heart disease, diabetes and atherosclerosis [32,33,34,35,36]. Moderate wine drinking may 
decrease psychological stress, which is a possible coronary artery disease risk factor. All of 
these effects are related to “light” drinking, which is defining as less than 3 standard drinks 
per day, heavy drinking(≥ 3 standard drinks per day)can be catastrophic in terms of 
cardiovascular health [27]. On the other hand alcohol abuse has undoubtedly negative effects 
including alcohol dependence syndrome, liver cirrhosis, alcoholic cardiomyopathy, systemic 
hypertension, hemorrhagic stroke, heart rhythm disturbances, encephalopathies, 
polyneuropathy, dementia [27,37]. 
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The epidemiological data indicate that light drinking has a beneficial effect on health 
[4]. One meta-analysis shows that drinking wine has a protective effect against cardiovascular 
risk and reduces total mortality, which is probably associated with the presence of high 
concentrations of polyphenols in wine. We do not observe this effects in drinking spirits, due 
to the lowest polyphenolic concentration [26,38]. Two studies show that low and moderate 
wine drinking, decrease mortality of coronary artery disease [39,40]. Nevertheless, one study 
of 32 826 women enrolled in the Nurses Health Study followed up from 1990 to 1998 and 18 
225 men enrolled in the Health Professionals Follow-Up Study followed up from 1994 to 
2000 and second prospective study among 85,709 women, 34 to 59 years of age show no 
differences in health benefits between moderate drinking of any types of drink [41,42]. 
4. Wine and cancer prevention 
Ethanol is classified by International Agency for Research on Cancer (IARC) as 
carcinogenic to humans. Its carcinogenic effect depends on the amount of alcohol consumed 
and increases with increasing consumption of ethanol. Epidemiological data are hard to 
analyze due to the presence of other risk factors for cancer such as smoking, diet, family 
history or hormone-replacement therapy [11].Available data is still inconclusive in terms of 
low alcohol intake and reduced risk of cancer. There is evidence that wince consumption 
decreases the risk of cancer of upper digestive tract, lung, colon, basal cell carcinoma, non-
Hodgkin lymphoma and prostate [43,44].  The protective effect of moderate wine 
consumption on cancer may be mainly attributed to polyphenols [43]. As with cardiovascular 
disease, resveratrol seems to have the greatest importance. Studies show that “light” drinking 
of wine may reduce the  risk of developing lung cancer [45]. A study on female with non-
Hodgkin's lymphoma showed that moderate wine intake increased 5-year survival to 75% 
from 69% in abstainers [46]. However, excessive alcohol consumption increases the risk of 
death of people with non-Hodgkin lymphoma compared to abstainers [47]. Drinking about 1 
glass of wine per day decreases the risk of developing Barrett’s esophagus, compared to 
heavy-drinkers and abstainers [48].There are several mechanisms in which resveratrol inhibits 
promotion and progression of the cancer process. This mechanisms are inhibition of 
cytochrome P450 enzymes, antioxidant, anti-inflammatory activities, and effects on cell 
cycle, cellproliferation and apoptosis [43]. Anti-tumor initiation activity of resveratrol is 
based on its antioxidant properties.  Oxidative stress plays a dominant part in the causation of 
carcinogenesis [21]. Studies conducted in vitro have discovered that resveratrol exerts an anti-
proliferative activity by inducing apoptosis [49]. It also modulates signal transduction, 
immune response, transcription factors, growth factors, cytokines, caspases, interleukins, 
prostaglandin synthesis and cell cycle-regulating proteins [11].Experimental studies show its 
anticarcinogenic properties [50]. It should be remembered that moderate drinking of alcohol 
has many disadvantages. There are reports that even light or moderate alcohol consumption 
can contribute to development of breast cancer, which is caused by increased levels of 
estrogen and the production of reactive oxygen species during alcohol metabolism [51,52]. 
Another study also shows that alcohol consumption increases the risk of breast cancer in post-
menopausal women [53].  
5. Wine and diabetes mellitus type 2 
Type 2-diabetes mellitus is affected mainly by lifestyle. The aim of therapy for diabetes is 
to keep the blood glucose level at optimum level. One of the therapeutic goals is inhibition of 
α-glucosidase [7]. Several studies show that red wine contains compounds that show strong 
inhibitory effect on α-glucosidase and α-amylase. α-glucosidase catalyzes the disaccharides 
distribution and α-amylase breaks down long-chain carbohydrates [54]. These effects may 
contribute to better control of postprandial glycemia. Wine flavonoids also inhibit glucose 
absorption in the intestine by sodium-dependent glucose transporter 1 (SGLT1). It stimulates 
insulin secretion and reduces hepatic glucose output [7].Flavonoids can also activate AMP-
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activated protein kinase (AMPK). AMPK activation modulates glucose and fatty acid 
metabolism, mitochondrial function, endoplasmic reticulum stress, autophagy, and apoptosis. 
In study on type 2 diabetic mice the AMPK activation was often accompanied by the up-
regulation of glucose transporter 4 (GLUT4) in skeletal muscle and the down-regulation of 
gluconeogenesis in the liver. This mechanism improves insulin sensitivity in the skeletal 
muscle and liver [55,56].  
6. Neuroprotection 
Neurodegenerative diseases, like Alzheimer's disease or Parkinson's disease, are mostly 
age-dependent disorders [57]. It is believed that onset of those diseases and subsequently 
neuronal death appears before first symptoms can be noticed. That means we do not know 
when was the beginning of the disease nor how late the treatment started.  Moreover, there is 
not enough information about how to prevent neurodegenerative diseases [58]. A study of 
Parkinson's disease showed that intake of dietary antioxidants was associated with a lower 
risk of Parkinson's disease [59]. A concept of wine-related compounds having neuroprotective 
and neurorescue effects starts to be accepted. Not only because of antioxidant activities of 
those compounds, but also via suppressing neuroinflammation, modulating signalling 
pathways, decreasing mitochondrial dysfunction and anti-aggregating properties [60]. 
Resveratrol shows antioxidant and anti-inflammatory effects, but the problematic issue is poor 
absorption of resveratrol [61]. Another study also indicates resveratrol as a potetnial substance 
in Alzheimer's disease treatment due to its multiple mechanisms in neuroprotection [62]. 
Wine polyphenols seems to be potentially neuroprotective agents, however, more clinical 
trials on this subject are needed [63]. 
7. Microbiota 
Microbiota is as name for microorganisms that can be found on a given habitat. Large 
intestine is a place where bacterial density reach 10
11–1012 bacteria per gram [64]. The 
composition of gut microbiota is changing throughout life especially during development and 
diet is one of the influencing factors [65]. The bioavailability of polyphenols is very low, so 
the vast majority of them persist into the colon [66,67]. Polyphenols may be considered as a 
potential substance in preventing or treating inflammatory gut disorders due to their 
antioxidant properties [68]. Polyphenols after intestinal transformations, firstly because of 
digestive enzymes and then due to the action of microbiota, may show strong antiviral, 
antibacterial, and antiparasitic activities [69]. However, these effects are not the only benefits 
of polyphenols, since there is a new concept of polyphenols as potential prebiotic candidates 
[66]. The meaning of the word ‘probiotic’ is ‘for live’ in greek, but  another, more specific 
definition is that it is “a nondigestible food ingredient that beneficially affects the host by 
selectively stimulating the growth and/or activity of one or a limited number of bacteria in the 
colon” [70]. Studies showed that two of the wine phenolic compounds are able to promote the 
growth of beneficial bacteria and the inhibition of pathogenic bacteria [71]. One of the studies 
which was a randomized, crossover, and controlled trial compared changes in micobiota of 
the participants who were asked to drink red wine, de-alcoholised red wine and gin for a 
specific period of time. Study showed significant changes in the fecal microbiota of all the 
participants depending on the kind of beverage consumed [72]. An increase of Bacteroides 
and Clostridium frequencies and a disappearance of Prevotellaceae were noticed after the 
period of ethanol (gin) consumption. The other thing is that the diversity of the fecal 
microbiota was higher after the red wine period. Phenolic compounds of red wine caused 
increase in the concentration of Firmicutes and Bacteroidetes, Enterococcus, 
Prevotella,Bifidobacterium, Bacteroidesuniformis, Eggerthellalenta, and Blautiacoccoides–
Eubacterium rectal. At the same time, there were no significant changes in Lactobacillus 
species concentration. These results showed that small ethanol doses plus polyphenol intake 
for a short time can modulate the composition of gut microbiota [72]. Another study 
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indicating that flavanols are able to influence the growth of specific large-intestinal bacteria 
showed this ability of  monomers catechin and epicatechin. Both of them, but in particular 
catechin is responsible of the growth of  C. coccoides–Eubacterium recital, which is a group 
of bacteria linked to the positive effects at the cellular and systemic level. Moreover, an 
increase of bifidobacteria was also noticed after catechin exposure, and this bacterial group 
present an ability to inhibit the growth of pathogenic micro-organisms [73]. It has been 
suggested the consumption of red wine increased the diversity of microbiota [74]. 
8. Summary 
All the protective effects on cardiovascular system, cancer prevention, type 2-diabetes 
mellitus, neuroprotection and microbiota composition that seem to come from red wine 
consumption are associated with the phenols contained in it. That means that moderate wine 
consumption that is a part of Mediterranean diet can be beneficial for our health. 
Nevertheless, any amount of alcohol consumed can lead to alcohol addiction and there is a 
very thin line between drinking small amounts and abuse. Furthermore, there are studies 
indicating that small amounts of alcohol can also have a negative impact on health. This 
subject still needs more studies and clinical trials. 
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